BEAMER project; BEhavioral and Adherence Model for improving quality, health outcomes and cost-Effectiveness of healthcaRe

Aad Liefveld

267 (updated: 02-11-2022 20:39)

10-11-2021 11:46

It doesn't get more patient centric than this!

BEAMER the latest EFPIA - European Federation of Pharmaceutical Industries and Associations Innovative Medicines Initiative (IMI) initiative is about finding a new and effective way to improve patient adherence to treatment.

BEAMER will focus on assessing and understanding patient needs. At Link2Trials we are honored to be part of a very motivated team that is eager to get patients better support, help HCP's better understand the patient's needs, and enable the Pharma industry to develop products and services that are better aligned to the patient's needs.

BEAMER Project

Like or Share

Choose category

Latest posts

09 March, 2023
Link2Trials Q&A_2
02 February, 2023
Link2Trials Q&A_1
31 October, 2022
Medication Non-Adherence in Rheumatology, Oncology and Cardiology: A Review of the Literature of Risk Factors and Potential Interventions
26 September, 2022
Over a year of hard work from the BEAMER team and the first deliverables are a fact.
08 September, 2022
Breederode University of Applied Sciences Rotterdam provides a 1-year specific training course for research nurses